AnaptysBio
ANAB
ANAB
119 hedge funds and large institutions have $1.02B invested in AnaptysBio in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
119
Holders Change
-8
Holders Change %
-6.3%
% of All Funds
2.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
54
Reduced
33
Closed
23
Calls
$20.3M
Puts
$18.6M
Net Calls
+$1.77M
Net Calls Change
+$7.31M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
$77.4M |
| 2 |
Morgan Stanley
New York
|
$7.17M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$46.3M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
$12.4M |
| 5 |
State Street
Boston,
Massachusetts
|
$38.2M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
$12M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
$87.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$9.72M |
| 4 |
Jennison Associates
New York
|
$0 |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
$20.2M |
